Crohn's disease clinical trials
381 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all crohn's disease studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting crohn's disease studies. A study counts once in each state where it has a site.
- New York43
- California39
- Texas39
- Florida35
- Ohio34
- Massachusetts29
- Pennsylvania28
- Georgia24
- Missouri24
- Washington24
- Illinois23
- Michigan23
Also in China (73), France (73), Italy (52), Canada (50), United Kingdom (43), Belgium (41), Germany (34), Poland (34).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 12
- Phase 111
- Phase 1 / Phase 212
- Phase 231
- Phase 2 / Phase 34
- Phase 328
- Phase 427
- No phase (devices, programs)113
- Observational153
Recently updated studies
Recruiting crohn's disease studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ages 18 Years – 75 Years · Dothan, Alabama · Phoenix, Arizona +63 more · AbbVie
- RecruitingObservationalNCT06579443
Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
Ages 18 Years and over · Coventry, West Midlands · Newcastle upon Tyne, West Midlands +3 more · University Hospitals Coventry and Warwickshire NHS Trust
- RecruitingObservationalNCT07619547
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Ages 18 Years – 85 Years · Bethesda, Maryland · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Ages 16 Years – 80 Years · Dothan, Alabama · Glendale, Arizona +181 more · Hoffmann-La Roche
- RecruitingObservationalNCT00001184
Immune Regulation in Ulcerative Colitis or Crohn s Disease
Ages 1 Day – 75 Years · Bethesda, Maryland · National Institute of Allergy and Infectious Diseases (NIAID)
- RecruitingPhase 4NCT06997965
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Ages 18 Years and over · Miami, Florida · Orlando, Florida +6 more · Alimentiv Inc.
- RecruitingPhase 4NCT05928039
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
Ages 18 Years and over · Calgary, Alberta · Edmonton, Alberta +14 more · University of Calgary
- RecruitingPhase 4NCT07872449
Risankizumab for Refractory Perianal Fistulizing Crohn's Disease
Ages 15 Years and over · Nishinomiya, Japan · Shinjuku-Ku, Japan +1 more · Yuki Horio
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.